Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2005-6-10
pubmed:abstractText
To determine the safety, dosing schedules, pharmacokinetic profile, and biologic effect of orally administered histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) in patients with advanced cancer.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-10561185, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-11423116, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-11443220, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-11713097, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-11854457, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-11893494, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-11992124, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-12189205, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-12402037, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-12515714, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-12526789, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-14506144, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-14976143, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-15327890, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-2185339, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-7459811, http://linkedlifedata.com/resource/pubmed/commentcorrection/15897550-8723390
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3923-31
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.
pubmed:affiliation
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY 10021, USA. kellyw@mskcc.org
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Clinical Trial, Phase I, Research Support, N.I.H., Extramural